Glaucoma Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):– 

https://shorturl.at/rPKS6

The global glaucoma market reached US$ 8.36 billion in 2023 and is expected to reach US$ 12.77 billion by 2031, growing at a CAGR of 5.5% during the forecast period 2024-2031.

List of the Key Players in the  Glaucoma Market:

Novartis AG, Bausch + Lomb., Viatris Inc., AbbVie., Alcon Inc., Thea Pharma Inc., Pfizer Inc., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries, Inc., Somerset Pharma LLC among others.

Emerging Players

Metcela Inc., Inspira-Technologies OXY B.H.N. LTD., LIVANOVA PLC

Industry Development:

In October 2024, Spinogenix, Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics that restore synapses and enhance patient outcomes, announced the integration of world-renowned clinical and research expertise in glaucoma. This strategic move supports the company’s upcoming program to evaluate SPG302 as a potential neuroprotective treatment for glaucoma. SPG302, an orally administered small-molecule therapy in clinical development, demonstrates a unique ability to rapidly regenerate glutamatergic synapses, positioning it as a cutting-edge advancement in glaucoma treatment.

Growth Forecast Projected:

The Global  Glaucoma Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Glaucoma Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the  Glaucoma Market:

By Type: Open-Angle Glaucoma, Angle-Closure Glaucoma, Congenital Glaucoma, Others

By Treatment Type: Prostaglandins, Beta Blockers, Alpha-Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Miotics, Rho Kinase Inhibitors, Implants, Others

By Age Group: Children, Adults, Geriatrics

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Analysis for Glaucoma Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

 Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com 
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com